Skip to content

Study · Case report or series · n = 1 · 2023

2 results

Diagnosis and management of vaginal leiomyoma: a case report and literature review.

Chen M, Li Y, Chi Y, Xia E

Ginekologia polska4 Jan 2023Cited by 4 (Europe PMC)

PMID36597753 (opens in a new tab)DOI10.5603/gp.a2022.0145 (opens in a new tab)PepBankPUB-36597753
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a 50-year-old woman with a vaginal leiomyoma, surgery with an oxytocin diluent water pad had little or negligible intraoperative bleeding.

    In plain wordsIn one woman with a vaginal fibroid, surgery that used diluted oxytocin had little or negligible bleeding.

    Peptide
    Oxytocin
    Outcome
    Not applicableIntraoperative bleeding
    Study

    n = 1

    Outcome group
    Bleeding and clotting · Reproductive and sexual health
    Studied dose
    Dose not stated · injection into the tissue space during surgeryAs given in this study (human).

    Source sentences

    Summary
    There was little or negligible intraoperative bleeding
    1 context sentence
    Summary · context
    We used oxytocin diluent injection during surgery to create a water pad in the tissue space and then performed a transvaginal myomectomy.
  2. 02HumanCase report or seriesSafety outcome

    In a 50-year-old woman with a vaginal leiomyoma, surgery with an oxytocin diluent water pad had no peripheral tissue injury, postoperative complications, incision dehiscence or surgical site infection.

    In plain wordsIn one woman with a vaginal fibroid, surgery that used diluted oxytocin had no tissue injury, wound problems or infection.

    Peptide
    Oxytocin
    Outcome
    No significant changeTissue injury and postoperative complications
    Study

    n = 1

    Outcome group
    Adverse events · Reproductive and sexual health
    Studied dose
    Dose not stated · injection into the tissue space during surgeryAs given in this study (human).

    Source sentences

    Summary
    no peripheral tissue injury, early or late postoperative complications, incision dehiscence, and no surgical site infection.
    1 context sentence
    Summary · context
    We used oxytocin diluent injection during surgery to create a water pad in the tissue space and then performed a transvaginal myomectomy.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:48 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.